Studies have shown that apoptosis is increased in patients with SLE, and both apoptosis and autoantibodies are important factors related to disease activity in the pathogenesis of SLE.[39] These findings are consistent with our findings that the mitochondria-related gene CASP9 is negatively correlated with SLE risk. Here, CASP9 is linked to systemic lupus erythematosus.